Introduction
============

Krüppel-like factors (KLFs) are members of the zinc-finger family of transcription factors named after their similarity to the *Drosophila*gap gene *Krüppel*\[[@B1]\]. KLFs are characterised by a DNA-binding motif containing three well-conserved C2H2 zinc-finger domains located in the carboxy terminal of the protein capable of binding GC-rich sequences, such as CACCC elements present in the proximal promoters of many eukaryotic genes \[[@B2]-[@B7]\]. The transcriptional regulatory domains located in the amino terminal of different KLFs are variable, resulting in their ability to interact with co-activators and/or co-repressors, culminating in the activation or repression of a given promoter activity. The presence of variable structural motifs outside of the DNA-binding domain of the KLF family members is reflected in their functional diversity \[[@B3],[@B8]\]. Characteristic features, nomenclature, evolution and functions of the human KLFs are reviewed here.

Characteristic features of the zinc-finger domain in KLFs
=========================================================

The 81-amino acid DNA-binding zinc-finger domain is highly conserved among the members of the KLF family, with more than 65 per cent amino acid sequence identity among the family members. The specific amino acids critical for DNA binding are highly conserved, imparting an ability to different KLFs that interact with similar *cis*-elements, such as GT boxes or GC-rich sequences like CACCC. The C~2~H~2~zinc finger present in the KLFs consists of two short beta strands followed by an alpha helix. In the classical C~2~H~2~zinc-finger domain, two conserved cysteines and histidines coordinate a zinc ion. The pattern of amino acid arrangement in a classical zinc finger is as follows: \#-X-C-X(1-5)-C-X3-\#-X5-\#-X2-H-X(3-6)-\[H/C\], where C, H and X correspond to cysteine, histidine and any amino acid, respectively, and numbers indicate the number of residues separating the flanking amino acids. The amino acids that are important for the stable fold of the zinc finger are marked with the \# symbol. The amino acid occupying the final position can be either histidine or cysteine. The linker sequence in between the zinc-finger domains (TGE(R/K)P(Y/F)X) is also highly conserved in KLF proteins \[[@B9]\].

Nomenclature of KLFs
====================

The nomenclature of KLFs has evolved over the years. KLFs were initially named after the tissue in which they were detected or highly expressed, such as erythroid KLF (EKLF or KLF1),\[[@B10]\] lung KLF (LKLF or KLF2),\[[@B11]\] gut-enriched KLF (GKLF/EZF or KLF4),\[[@B12]-[@B15]\] and intestinal-enriched KLF (IKLF or KLF5; also called BTEB2) \[[@B16],[@B17]\]. A few other KLFs were named after the elements they bound, such as the core promoter-binding protein (CPBP/Zf9 or KLF6),\[[@B18],[@B19]\] basic transcription element-binding protein (BTEB1 or KLF9),\[[@B20]\] or by their physiological responses, such as transforming growth factor-β-inducible early genes 1 and 2 (TIEG1 and TIEG2 or KLF10 and KLF11, respectively) \[[@B21],[@B22]\]. Considering that the tissue expression of KLFs, the range of their nucleotide recognition sequences and their ability to regulate diverse functions is much broader than initially understood, the use of numerical nomenclature based on the chronological order of discovery (such as KLF1, KLF2, KLF3. . .) is recommended by the Human Genome Organization Gene Nomenclature Committee (HGNC) to avoid misleading connotations providing partial descriptions of their expression and/or function. A search of the HGNC website <http://www.genenames.org/index.html> for \'Krüppel-like factor\' on 26th January 2010 identified 17 *KLF*genes in the human genome. Names, chromosomal locations, sequence accession IDs, previous symbols and aliases, if any, for these KLFs are given in Table [1](#T1){ref-type="table"}. Several other related proteins, such as the members of the Sp family of proteins, GLI2, GLI3, and the pseudogene *KLF7P*, are not included in this list, for the sake of brevity.

###### 

Names, chromosomal locations, number of exons, sequence accession IDs, previous symbols and aliases, if any, for different KLFs.

  -----------------------------------------------------------------------------------------------------------------------------------------
  Gene symbol   Gene name                Gene location     Number of exons   Sequence IDs         Previous symbols/aliases
  ------------- ------------------------ ----------------- ----------------- -------------------- -----------------------------------------
  *KLF1*        Krüppel-like factor 1\   19p13.13-p13.12   3                 U37106 NM_006563     EKLF
                (erythroid)                                                                       

  *KLF2*        Krüppel-like factor 2\   19p13.13-p13.11   3                 AF123344             LKLF
                (lung)                                                                            

  *KLF3*        Krüppel-like factor 3\   4p14              6                 AF285837             BKLF
                (basic)                                                                           

  *KLF4*        Krüppel-like factor 4\   9q31              5                 AF022184 NM_004235   EZF, GKLF
                (gut)                                                                             

  *KLF5*        Krüppel-like factor 5\   13q22.1           4                 D14520               BTEB2, IKLF, CKLF
                (intestinal)                                                                      

  *KLF6*        Krüppel-like factor 6    10p15             4                 U51869               BCD1, ST12, COPEB, CPBP, GBF, Zf9, PAC1

  *KLF7*        Krüppel-like factor 7\   2q32              4                 AB015132 NM_003709   UKLF
                (ubiquitous)                                                                      

  *KLF8*        Krüppel-like factor 8    Xp11.21           6                 U28282 NM_007250     BKLF3, ZNF741, DXS741

  *KLF9*        Krüppel-like factor 9    9q13              2                 BC069431 NM_001206   BTEB1

  *KLF10*       Krüppel-like factor 10   8q22.2            4                 U21847               TIEG, EGRA, TIEG1

  *KLF11*       Krüppel-like factor 11   2p25              4                 AF028008 NM_003597   TIEG2, TIEG3

  *KLF12*       Krüppel-like factor 12   13q22             8                 AJ243274 NM_007249   AP-2rep, HSPC122, AP2REP

  *KLF13*       Krüppel-like factor 13   15q12             2                 AF132599 NM_015995   RFLAT-1, BTEB3, NSLP1, FKLF-2

  *KLF14*       Krüppel-like factor 14   7q32.3            1                 AF490374 NM_138693   BTEB5

  *KLF15*       Krüppel-like factor 15   3q13-q21          3                 AB029254 NM_014079   KKLF

  *KLF16*       Krüppel-like factor 16   19p13.3           2                 AF327440             NSLP2, BTEB4, DRRF

  *KLF17*       Krüppel-like factor 17   1p34.1            4                 BC049844 NM_173484   ZNF393, Zfp393, FLJ40160
  -----------------------------------------------------------------------------------------------------------------------------------------

Evolution of KLFs
=================

KLFs are closely related to the Sp family of zinc-finger transcription factors, of which there are nine members in the human genome (Sp1-Sp9). Currently, there are 17 KLFs annotated in the human genome. The high level of conservation of structure and function of KLF proteins in different species is a reflection of their ancient evolutionary history. The 17 genes encoding different KLFs are scattered all over the human genome, and there are also 17 *Klf*genes in the mouse genome. This indicates that these genes are ancient and suggests the involvement of gene duplications and translocations in their evolution.

The exon-intron organisation of human *KLF*genes is not well conserved. For example, while *KLF12*has eight exons, *KLF14*is encoded on a single exon (Table [1](#T1){ref-type="table"}). Based on an extensive phylogenetic analysis with the amino acid sequences of KLF proteins from different species, it was proposed that the mammalian *KLF*genes have evolved in two phases - the first in the chordate lineage, during the early emergence of vertebrates, and the second in the mammalian lineage \[[@B23]\]. This phylogenetic analysis also identified six different ascidian zinc-finger proteins as the ancestral genes for the distinct subgroups of vertebrate *KLF*genes \[[@B23]\]. In view of the intron-less nature of *KLF14*and its homology with *KLF16*, it has been suggested that *KLF14*is an ancient retrotransposed copy of *KLF16*\[[@B24]\]. Phylogenetic analysis of the 17 human KLF complete amino acid sequences by the neighbour-joining method using the ClustalW2 program <http://www.ebi.ac.uk/Tools/es/cgi-bin/clustalw2> indicated that KLFs 5, 17 and 8 are related more to each other than to the rest of the KLFs, which are further grouped into two major clades (Figure [1](#F1){ref-type="fig"}). According to this analysis, KLFs 9 and 16 are the most recent KLFs to have diverged from each other, followed by KLFs 6 and 7 (Figure [1](#F1){ref-type="fig"}). This is consistent with the similar expression pattern, common ability to interact with mSin3A (a core component of a large multiprotein co-repressor complex with associated histone deacetylase enzymatic activity) and shared cellular function of cell cycle regulation attributed to KLFs 9 and 16 (Table [2](#T2){ref-type="table"}).

![**Phylogenetic tree generated using the complete amino acid sequence of human KLF proteins by ClustalW2 web-based program**<http://www.ebi.ac.uk/Tools/es/cgi-bin/clustalw2>. Evolutionary distances are shown next to the corresponding names.](1479-7364-4-4-263-1){#F1}

###### 

Expression pattern, interacting co-factors, effect on gene expression and known functions of different *KLFs*.

  Gene      Expression pattern                                             Interacting co-factors                             Cellular function                                                                                                                                                References
  --------- -------------------------------------------------------------- -------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------
  *KLF1*    Erythroid and mast cells                                       P300/CBP, PCAF, SWI.SNF and mSin3A                 Erythropoiesis, cell cycle                                                                                                                                       \[[@B25],[@B26]\]
  *KLF2*    Lung, blood vessels, lymphocytes                               WWP1                                               Adipogenesis, lung and blood vessel development, T-cell migration, monocyte activation                                                                           \[[@B27]-[@B30]\]
  *KLF3*    Adipocytes, brain and erythroid tissue                         CtBP2, FHL3                                        Adipogenesis                                                                                                                                                     \[[@B31],[@B32]\]
  *KLF4*    Gut, skin, cornea and several other epithelial tissues         HDAC, p300/CBP, b-catenin/TCF4, Oct4, Sox2, CtBP   Epithelial barrier formation, goblet cell development, adipogenesis, stem cell maintenance, control of cell proliferation, regulation of neuronal regeneration   \[[@B33]-[@B39]\]
  *KLF5*    Gut, skin, lung, cornea and several other epithelial tissues   P53, HDAC1, PARP1, PIAS1                           Cell growth, lung development, cardiac remodelling, stem cell maintenance                                                                                        \[[@B40]-[@B45]\]
  *KLF6*    Ubiquitous                                                     HDAC3                                              Tumour suppressor                                                                                                                                                \[[@B46]\]
  *KLF7*    Ubiquitous                                                     MoKA                                               Cell proliferation, neuronal differentiation, olfactory bulb development                                                                                         \[[@B47]-[@B51]\]
  *KLF8*    Ubiquitous                                                     CtBP2                                              Cell proliferation, epithelial to mesenchymal transition                                                                                                         \[[@B52]-[@B55]\]
  *KLF9*    Ubiquitous                                                     mSin3A                                             Neurite outgrowth, carcinogen metabolism, intestinal epithelial development                                                                                      \[[@B56]-[@B58]\]
  *KLF10*   Ubiquitous                                                     mSin3A                                             Apoptosis, cell proliferation                                                                                                                                    \[[@B22],[@B59]\]
  *KLF11*   Ubiquitous                                                     mSin3A, p300                                       Cell proliferation                                                                                                                                               \[[@B60],[@B61]\]
  *KLF12*   Brain, kidney, liver and lung                                  CtBP1                                              Cancer progression                                                                                                                                               \[[@B62],[@B63]\]
  *KLF13*   Ubiquitous                                                     mSin3A, p300, PCAF                                 Cell proliferation, carcinogen metabolism                                                                                                                        \[[@B64],[@B65]\]
  *KLF14*   Ubiquitous                                                     mSin3A, HDAC2                                      Lipoprotein metabolism, basal cell carcinoma, TGF-β signalling                                                                                                   \[[@B66]-[@B68]\]
  *KLF15*   Ubiquitous                                                     Sp1, MEF2A                                         Cardiomyocyte hypertrophy, gluconeogenesis                                                                                                                       \[[@B69]-[@B71]\]
  *KLF16*   Ubiquitous                                                     mSin3A                                             Carcinogen metabolism, cell cycle                                                                                                                                \[[@B65],[@B72]\]
  *KLF17*   Testis, brain and bone                                         Not known                                          Epithelial-mesenchyme transition                                                                                                                                 \[[@B73],[@B74]\]

Key

TGF-β, transforming growth factor-beta.

Functions of KLFs
=================

By virtue of their ability to activate and/or repress the expression of a large number of genes, KLFs regulate a diverse array of developmental events and cellular processes such as haematopoiesis,\[[@B75],[@B76]\] cardiac remodelling,\[[@B77]\] adipogenesis,\[[@B27],[@B31],[@B46],[@B78]-[@B82]\] maintenance of stem cells,\[[@B83]-[@B86]\] epithelial barrier formation,\[[@B87]-[@B90]\] control of cell proliferation and neoplasia,\[[@B91]-[@B93]\] flow-mediated endothelial gene expression,\[[@B94],[@B95]\] skeletal and smooth muscle development,\[[@B96]\] gluconeogenesis,\[[@B69]\] monocyte activation, intestinal and conjunctival goblet cell development,\[[@B33],[@B97]\] ocular surface integrity,\[[@B33],[@B34]\] retinal neuronal regeneration \[[@B98]\] and neonatal lung development \[[@B40]\] (Table [2](#T2){ref-type="table"}). This functional diversity of KLFs is consistent with the variable amino terminal regulatory domains in different KLFs that allow interaction with a diverse array of co-factors. For example, KLFs 3, 8 and 12 interact with carboxy-terminal binding protein (CtBP) co-repressors through the PVDL(S/T) repressor domain, while KLFs 9, 10, 11, 13 and 16 interact with histone deacetylases (HDACs) through a Sin3 interaction domain (SID), both resulting in transcriptional repression. KLF4 interacts with co-activators such as p300 and CBP (cyclic-AMP-response-element-binding-protein-binding-protein) to mediate transcriptional activation. KLF4 also has the ability to interact with HDACs, to repress transcription. The functional diversity of KLFs results in interesting conflicts, wherein different KLFs have antagonistic effect(s) on individual cellular processes. For example, KLF4 suppresses cell proliferation, while KLF5 promotes it. Similarly, adipogenesis is supported by KLFs 4, 5 and 15, but is suppressed by KLFs 2 and 3.

Future directions
=================

A large body of work over the past 25 years has established the KLFs as critical regulators of diverse functions in many parts of the body. In spite of this progress in our understanding of the properties of KLFs, much remains to be uncovered. In order fully to understand the properties of KLFs in diverse spatio-temporal contexts and physiological conditions, it is crucial to identify (a) the co-factors that they interact with; (b) their target genes; (c) the signal transduction pathways by which they are regulated; and (d) their unique tissue-specific roles using conditional knockouts. It is expected that these avenues of research will lead to exciting discoveries regarding the involvement of KLFs in human health and disease.
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